UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000003433 |
|---|---|
| Receipt number | R000004157 |
| Scientific Title | The phase II study for evaluating the effectiveness and safety of allogeneic hematopoietic stem cell transplantation for adult acute myeloid leukemia with FLT3/ITD mutation. -JALSG AML209-FLT3-SCT Study (AML209-FLT3-SCT)- |
| Date of disclosure of the study information | 2010/04/02 |
| Last modified on | 2020/04/09 10:45:02 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2010/04/02 08:45:33 | ||
| 2 | Update | 2014/04/02 10:20:48 | Division name Division name TEL TEL Division name Division name TEL Post marketing survey by drug manufacture etc., specified by Japanese law. |
|
| 3 | Update | 2014/04/02 10:21:48 | Division name Division name |
|
| 4 | Update | 2015/04/02 09:06:01 | Type of intervention Key exclusion criteria Key exclusion criteria |
|
| 5 | Update | 2015/04/02 09:06:43 | TEL TEL TEL |
|
| 6 | Update | 2015/04/02 09:07:39 | Recruitment status |
|
| 7 | Update | 2016/04/02 11:10:32 | Name of primary person or sponsor Organization |
|
| 8 | Update | 2016/04/02 11:11:22 | Recruitment status |
|
| 9 | Update | 2017/10/07 12:08:47 | Last follow-up date |
|
| 10 | Update | 2017/10/07 12:10:42 | Last follow-up date |
|
| 11 | Update | 2020/04/09 10:40:02 | Date of IRB |
|
| 12 | Update | 2020/04/09 10:45:02 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Organization Organization Organization Address Address Tel |
